Zimbabwe has turned down a major US health deal valued at 367 million US dollars (272 million pounds) over five years because of Washington's insistence on sensitive data.
The decision was revealed following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "skewed".
An official spokesperson later stated that the United States was demanding access to biological samples for scientific study and commercial purposes while was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for more dialogue to secure a agreement acceptable to all parties so the country's vital HIV treatment initiative can continue.
Wider Background
This development follows a comparable case in neighbouring Kenya, where a court blocked a related deal with the US following legal challenges were raised about the safety of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and responsibility.
Based on statements, 16 African countries have so far agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to share its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our country would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our population if a new disease outbreak emerge."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting structures previously established through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.
"This framework is intended to ensure that when a nation contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "are not meant as opposition to America," he added.
"We welcome further dialogue with our American counterparts on how subsequent co-operation might be structured in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but suggested that talks should continue given that a large portion of the nation's HIV programmes depended on external financing.
"If technical issues arise, including those involving data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," the group said.
The situation highlights the continuing debate between accepting crucial international aid and protecting national sovereignty in an increasingly interconnected world.